Low/Intermediate PCa Video Chat, March 9, 2026
Low/Intermediate PCa Video Chat, March 9, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
- Men (Only) Speaking Freely on the 1st & 3rd Thursdays at 8.00 pm Eastern https://ancan.org/men-speaking-freely/
- Veterans Healthcare Navigation on the 1st & 3rd Tuesdays at 8.00 pm Eastern https://ancan.org/veterans/
- Veterans Speaking Freely on the 4th Tuesday at 8:00 pm Eastern https://ancan.org/speaking-freely/
- You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
- Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Editor’s Pick: The value of connecting with other AnCan peers to compare doctor recommendations and treatment experiences. (bj)
Topics Discussed
Management of Benign Prostatic Hyperplasia (BPH) and prostate size; comparison of radiation modalities such as stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT), magnetic resonance-guided linear accelerator (MRI-Linac) and brachytherapy; comparison of androgen deprivation therapy (ADT) medications: Orgovyx vs Lupron; importance of genomic tests like Decipher, Prolaris, Artera AI, and the PROMISE study (germline testing); discussion on surgical options and surgeon recommendations; advantages of transperineal over transrectal biopsies; benefits of MRI-fusion biopsies for targeted sampling; veterans get medical treatments through Veterans Affairs (VA) can use Community Care to get access to specialized medical care outside the VA; lymph node involvement seen in a PSMA scan changes disease categorization and requires more advanced drugs; importance of consulting a cardio-oncologist when adding ADT treatments for prostate cancer while recovering from heart surgery; discussion between how long a low/intermediate prostate cancer patient can wait between a diagnosis requiring an active treatment (such as prostatectomy, radiation, hormone therapy) and starting active treatment; the value of connecting with other AnCan peers at similar stages of their journey to compare doctor recommendations and treatment experiences.
Chat